SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Multiple Sclerosis
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Matá, S.
Right arrow Articles by Link, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Matá, S.
Right arrow Articles by Link, H.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Multiple sclerosis is associated with enhanced B cell responses to the ganglioside GD I a

Sabrina Matá

Dipartimento di Scienze Neurologiche e Psichiatriche, Servizio di Neurofisiopatologia, Università di Firenze, viale Morgagni 85, 1-50134 Firenze, Italy

Francesco Lolli

Dipartimento di Scienze Neurologiche e Psichiatriche, Servizio di Neurofisiopatologia, Università di Firenze, viale Morgagni 85, 1-50134 Firenze, Italy

Mats Söderström

Department of Neurology, Karolinska Institute, Huddinge University Hospital S-141 86 Huddinge, Sweden, Department of Opthalmology, Karolinska Institute, Huddinge University Hospital S-141 86 Huddinge, Sweden

Francesco Pinto

Dipartimento di Scienze Neurologiche e Psichiatriche, Servizio di Neurofisiopatologia, Università di Firenze, viale Morgagni 86, 1-50134 Firenze, Italy

Hans Link

Department of Neurology, Karolinska Institute, Huddinge University Hospital S-141 86 Huddinge, Sweden

The occurrence and role of autoantibodies to gangliosides and other lipid-containing components of the central nervous system in Multiple Sclerosis (MS) are unsettled Using sensitive ELISAs, we measured IgG and JgM antibody titers and absorbances to the three major gangliosides GDIa, GD l b and GM, and to sulfatides, cardiolipin and myelin proteins in paired serum and cerebrospinal fluid (CSF) from patients with untreated MS, optic neuritis (ON), acute aseptic meningo-encephalitis (AM) and other neurological diseases (OND). Twenty-three per cent of 30 MS (P < 0.04) and 18% of 32 ON patient (P <0.05) presented elevated IgG antibody titers to GD) a in serum compared to 9% of patient with OND. Six (40%) of the patient with malignant MS had elevated serum IgG antibody titers to GD) a compared to one (6%) of th e patient with benign MS (P <0.04). In CSF, elevated IgG antibody titers to GDIa were measured in 13% of MS and 20% of ON patient compared to 4% of patient with OND (P < 0.03 and P < 0.02, respectively). The augmented IgG response to GD) a in serum also separated MS from Guillain-Barr6 syndrome. Compared to OND increased JgM absorbances to sulfatides and cardiolipin were observed in CSF of patient with MS, but also in AM. Elevated IgG antibody titers to myelin proteins were found more often in MS patient' serum and MS, ON and AM patient' CSF compared to OND. The data implicate that among the multitude of enhanced B-cell responses occurring in MS and ON, that directed to GD I a is common and more discriminative, and should be evaluated in future MS treatment studies.

Key Words: multiple sclerosis • optic neuritis • ganglioside • autoantibodies • cardiolipin • sulfatide

Multiple Sclerosis, Vol. 5, No. 6, 379-388 (1999)
DOI: 10.1177/135245859900500i603


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
Mult SclerHome page
M Podbielska and E. Hogan
Molecular and immunogenic features of myelin lipids: incitants or modulators of multiple sclerosis?
Multiple Sclerosis, September 1, 2009; 15(9): 1011 - 1029.
[Abstract] [PDF]


Home page
J. Neurosci.Home page
H. C. Lehmann, P. H. H. Lopez, G. Zhang, T. Ngyuen, J. Zhang, B. C. Kieseier, S. Mori, and K. A. Sheikh
Passive Immunization with Anti-Ganglioside Antibodies Directly Inhibits Axon Regeneration in an Animal Model
J. Neurosci., January 3, 2007; 27(1): 27 - 34.
[Abstract] [Full Text] [PDF]


Home page
Mult SclerHome page
S Marconi, M Acler, L Lovato, L De Toni, E Tedeschi, E Anghileri, S Romito, C Cordioli, and B Bonetti
Anti-GD2-like IgM autoreactivity in multiple sclerosis patients
Multiple Sclerosis, June 1, 2006; 12(3): 302 - 308.
[Abstract] [PDF]


Home page
NeurologyHome page
L. M. Villar, J. Masjuan, P. Gonzalez-Porque, J. Plaza, M. C. Sadaba, E. Roldan, A. Bootello, and J. C. Alvarez-Cermeno
Intrathecal IgM synthesis predicts the onset of new relapses and a worse disease course in MS
Neurology, August 27, 2002; 59(4): 555 - 559.
[Abstract] [Full Text] [PDF]



Advertisement